We demonstrated that changes in methylation levels were occurring in the NCAPH2/LMF2 promoter region in AD and aMCI [10] and our findings suggested that there were changes in methylation levels in many other regions besides this one. The gene discussed is NCAPH2; the disease is Alzheimer disease.